GenomicDAO is a platform that initiates, drives, and governs precision medicine research and development; especially for underrepresented populations, such as Asians, Hispanics, and Africans. GenomicDAO replaces the monopolistic precision medicine space, dominated by a few nations and corporations focused on the European genome, with democratized and decentralized precision medicine research and development governance. 

GenomicDAO is designed to allow any individual to start partaking in the cause of Precision Medicine. Users can choose to contribute their resources, such as funds or genetic data to the cause that is of their aligned interest. The operating model breaks down the research and development process, significantly reducing the upfront costs to fund such initiatives, and allowing GenomicDAO to accelerate product development. 

PCSP is the governance and utility token of Stroke-Prevention GenomicDAO:

• GenomicDAO utilizes the PCSP token for various rewarding scheme
• PCSP holders have the right to govern GenomicDAO Post-Covid Stroke Prevention development
• Users can use PCSP to exchange for vouchers and discount coupons applied on end products
• Advocates can hold and stake PCSP to earn a higher commission on product sales.